ribavirin has been researched along with von Willebrand Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Altisent, C; Esteban, JI; Esteban, R; Guardia, J; Puig, L; Sauleda, S | 1 |
| Berntorp, E; Lethagen, S; Lindgren, S; Verbaan, H; Widell, A | 1 |
2 other study(ies) available for ribavirin and von Willebrand Diseases
| Article | Year |
|---|---|
Treatment with interferon plus ribavirin in anti-HIV negative patients with congenital coagulation disorders and chronic hepatitis C.
Topics: Adolescent; Adult; Age Factors; Age of Onset; Alanine Transaminase; Antiviral Agents; Blood Coagulation Disorders; Child; Chronic Disease; Drug Therapy, Combination; Factor VII Deficiency; Female; Hemoglobins; Hemophilia A; Hemophilia B; Hepacivirus; Hepatitis C; HIV Antibodies; HIV Seronegativity; Humans; Interferons; Male; Middle Aged; Neutrophils; Platelet Count; Predictive Value of Tests; Prognosis; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin; RNA, Viral; Sensitivity and Specificity; Treatment Outcome; von Willebrand Diseases | 2000 |
Clinical spectrum of hepatitis C-related liver disease and response to treatment with interferon and ribavirin in haemophilia or von Willebrand disease.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Biopsy; Drug Therapy, Combination; Female; Fibrosis; Follow-Up Studies; Genotype; Hemophilia A; Hepatitis C; Humans; Interferon-alpha; Liver; Male; Middle Aged; Ribavirin; RNA, Viral; Treatment Outcome; Ultrasonography; von Willebrand Diseases | 2001 |